For the past four decades, oral antiretroviral therapy for HIV has required daily doses. Long-acting injectable cabotegravir ...
A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.
HIV health providers have already absorbed some cuts and fear more. They worry that gains made toward eliminating the virus are in jeopardy. The post ‘We are living in reverse.’ Fragile HIV funding ...
Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...
ART iniitiation, managing comorbidities addressed for aging patients ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...
The introduction of harsh penalties for same-sex relations has created a climate of fear that is severely disrupting HIV services. Gilbert Nakweya reports.
Aging with HIV comes with an increased risk of other health problems. Failing to get adequate care could undermine fighting the virus. (Story aired on Weekend Edition Saturday on June 15, 2024.) ...
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...
The height of the AIDS epidemic hit Cambodia in the late 90s. More than 180,000 people were infected. A full-on government effort to find at-risk populations and distribute medication has gotten the ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...